Skip to main content

Pharma IPOs: Evoke, Ophthotech

Ophthotech is a better offering than Evoke Pharma says Equities.com Francis Gaskins. Watch to find out why.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Scroll to Continue

TheStreet Recommends